A new program for store supervisors and department managers may make them better employees but may not help them reach the middle class.
NYS Entity Status
NYS Filing Date
DECEMBER 10, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - JMH MANAGEMENT CO., INC.
AROUND THE WEB
- At Walmart Academy, Training Better Managers. But With a Better Future?
By MICHAEL CORKERY - Tuesday Aug 8, 2017
- Listing of the Day: Woodside, California
Friday Jul 28, 2017
This mid-century modern home was recently renovated to highlight its original charm, but include all the modern updates of a true tech-elite lifestyle.
- Perfecting Pinot at Clos de la Tech
By Matt Kettmann - Thursday Aug 10, 2017
Right now, on very small blocks of his vineyards, which ride the ridge between Half Moon Bay and Woodside, underground probes are monitoring water absorption rates and radioing that information to a central computer, which then relays it to irrigation valves powered by thumbnail-size solar panels.“In a typical vineyard, you can find plants that are dying for water and undercropping, and you can find plants that are waterlogged and producing poor-quality fruit,” said Rodgers.The resulting technology — which Rodgers is starting to sell through his startup company WaterBit Inc. — is likely to conserve water and ensure more evenly dispersed and ripened grapes.The Waterbit technology will be a boon for large commercial grape growers and other fruit and vegetable farmers, who also use their irrigation systems to distribute fertilizers, called “fertigation.”“My propensity is to do everything 100 percent without any compromise,” explained Rodgers, who began reading academic journals on wine, started tinkering with ways to control and monitor fermentation temperatures, and even built his own press.In 2000, they took the brand commercial and bought two more pieces of vineyard property closer to the ridgetop, including the steeply sloped, ocean-facing property above La Honda where they built their winery into underground caves.Clos de la Tech was developing technology along a similar path, so he reached out, toured the vineyard (“one of the most meticulous”) and winery (“almost like Disneyland”), and gave his spiel about how valuable it would be to collect these aromas and then sell them to large commercial producers whose wines needed better bouquets.“The next thing I know, they’re flying me out there to talk about the aroma collection and utilization project,” said Goldfarb, who returned to work the 2012 harvest at Clos de la Tech and was then taught how to manage the vineyards by the renowned viticulturist Rex Geitner, who died in 2013.While the aromatic capture project is currently caught in a regulatory limbo — despite wide interest, it’s unclear whether the feds would treat it as distilling, and arcane state laws need some tweaking — Goldfarb, Massey and Rodgers continue to test the scalability of their integrated fermentation control system with UC Davis.Being surrounded by a commitment to making the best wine possible, and the intelligence creativity, and mind power that’s fueling the operation is really exciting and motivating.“If you bring that kind of scientific inquisitiveness to winemaking, where you throw in a living thing, from the ground to the grapes to the microorganisms, the complexity goes up by a factor of thousands,” said Rodgers, who can explain tannin molecule differences, anthocyanin ratios and quercitin creation at the deepest of levels.
- Abbvie’s hep C drug pricing threatens Gilead’s dominance
By Max Nisen - Tuesday Aug 8, 2017
Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- MTV Mines the Past for Its Future: ‘Total Request Live’
By JOHN KOBLIN - Sunday Jul 30, 2017
Remember the “TRL” studio and crowds in Times Square? Music? Carson Daly? MTV hopes you do, and will tune in again.